- Global Pharma News & Resources

Whole Genome Amplification Market Share 2023 to 2033 | By GE Healthcare, Sygnis AG, Illumina, Merck KGaA

The global Whole Genome Amplification Market sales is predicted to approach US$ 5.5 billion by the end of 2033, according to Future Market Insights (FMI), due to the growing need for Whole Genome Amplification in forensics and genetic disorders. The market is expected to reach US$ 2.8 billion in sales by 2023, with a CAGR of 7.0% between 2023 and 2033.

“On-chip cell capture and DNA extraction,” a new technology for Whole Genome Amplification, collects chromosomal DNA from single cells after extraction and fixes it in a micropillar array for isothermal amplification. Single cell on-chip WGA is intended to overcome the amplification biases of traditional single cell WGA and improve genome coverage, particularly in cancer cell genomes.

Get Sample Report + Related Graphs & Charts@

The ease of use provided by various WGA kits for the entire process has propelled the market throughout the years. To boost their revenue share, molecular testing companies are increasingly focused on developing novel devices and kits, such as WGA kits and complete WGA kits with enhanced capabilities. Adoption of this technology is expected to accelerate among research institutes, hospitals, diagnostic centres, and forensic labs, owing to the fact that it provides a more advanced method of genome amplification and sequencing.

Single Cell WGA Continues to Bring in New Applications

Massively parallel single-cell genome sequencing is likely to broaden our understanding of genetic variation in complex biological systems.

Single cell WGA is a technique that uses advanced next generation sequencing technology to examine sequence information from a single cell. By bringing the complete genome structure to a cellular level, this technique is recognised as a powerful tool for studying genetics.

Because this method produces a high-resolution image of the genomic material, its application in a wide range of biological areas, including microbiology, immunology, neuroscience, cancer research, and tissue mosaicism, will increase.

The key players of the market, including GE Healthcare, Sygnis AG, Illumina, Inc., Merck KGaA, Thermo Fisher Scientific Inc., and Active Motif are inclined more towards strategic acquisitions and mergers.

They are also looking for distribution and collaboration agreements to help improve their product reach. It will also help them serve end users better, with diagnostic consulting and good laboratory practices. High price point may remain a major challenge for companies.

For any queries linked with the report, ask an analyst@

Key Segments Covered in Whole Genome Amplification Market Study

By Product Type

  • Single Cell WGA Kit
  • Complete WGA Kit
  • WGA Re-Amplification Kit
  • WGA & Chip DNA Kit
  • Others

By Application

  • Drug Discovery & Development
  • Disease Diagnosis
  • Agriculture & Veterinary
  • Research
  • Forensics
  • Others

By End User

  • Pharma & Biotech Companies
  • Hospitals & Clinics
  • Contract Research
  • Organizations
  • Research & Academic Institutes
  • Others

Contact Sales for Further Assistance in Purchasing this Report@

About Future Market Insights, Inc.

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.


Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries:
Browse All Reports:

Editor Details

Last Updated: 17-May-2023